BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 38517402)

  • 1. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
    Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
    Clin Orthop Relat Res; 2023 Jun; 482(1):143-57. PubMed ID: 37306629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the SORG Orthopaedic Research Group Hip Fracture Delirium Algorithm Perform Well on an Independent Intercontinental Cohort of Patients With Hip Fractures Who Are 60 Years or Older?
    Oosterhoff JHF; Oberai T; Karhade AV; Doornberg JN; Kerkhoffs GMMJ; Jaarsma RL; Schwab JH; Heng M
    Clin Orthop Relat Res; 2022 Nov; 480(11):2205-2213. PubMed ID: 35561268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International external validation of the SORG machine learning algorithms for predicting 90-day and one-year survival of patients with spine metastases using a Taiwanese cohort.
    Yang JJ; Chen CW; Fourman MS; Bongers MER; Karhade AV; Groot OQ; Lin WH; Yen HK; Huang PH; Yang SH; Schwab JH; Hu MH
    Spine J; 2021 Oct; 21(10):1670-1678. PubMed ID: 33545371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the SORG machine learning algorithms for predicting 90-day and 1-year survival of patients with lung cancer-derived spine metastases: a recent bi-center cohort from China.
    Zhong G; Cheng S; Zhou M; Xie J; Xu Z; Lai H; Yan Y; Xie Z; Zhou J; Xie X; Zhou C; Zhang Y
    Spine J; 2023 May; 23(5):731-738. PubMed ID: 36706921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach.
    Jacobson D; Cadieux B; Higano CS; Henry DH; Bachmann BA; Rehn M; Stopeck AT; Saad H
    J Bone Oncol; 2022 Jun; 34():100423. PubMed ID: 35378840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
    Thio QCBS; Karhade AV; Ogink PT; Raskin KA; De Amorim Bernstein K; Lozano Calderon SA; Schwab JH
    Clin Orthop Relat Res; 2018 Oct; 476(10):2040-2048. PubMed ID: 30179954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the SORG 90-day and 1-year machine learning algorithms for survival in spinal metastatic disease.
    Karhade AV; Ahmed AK; Pennington Z; Chara A; Schilling A; Thio QCBS; Ogink PT; Sciubba DM; Schwab JH
    Spine J; 2020 Jan; 20(1):14-21. PubMed ID: 31505303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Machine Learning Algorithm for Predicting 6-Week Survival in Spinal Metastasis: An External Validation Study Using 2,768 Taiwanese Patients.
    Su CC; Lin YP; Yen HK; Pan YT; Zijlstra H; Verlaan JJ; Schwab JH; Lai CY; Hu MH; Yang SH; Groot OQ
    J Am Acad Orthop Surg; 2023 Sep; 31(17):e645-e656. PubMed ID: 37192422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of survival prediction models for bone metastases of the extremities following surgery.
    Park JH; Won J; Kim HS; Kim Y; Kim S; Han I
    Bone Joint J; 2024 Feb; 106-B(2):203-211. PubMed ID: 38295850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the SORG algorithm generalize to a contemporary cohort of patients with spinal metastases on external validation?
    Bongers MER; Karhade AV; Villavieja J; Groot OQ; Bilsky MH; Laufer I; Schwab JH
    Spine J; 2020 Oct; 20(10):1646-1652. PubMed ID: 32428674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased psoas muscle area is a prognosticator for 90-day and 1-year survival in patients undergoing surgical treatment for spinal metastasis.
    Hu MH; Yen HK; Chen IH; Wu CH; Chen CW; Yang JJ; Wang ZY; Yen MH; Yang SH; Lin WH
    Clin Nutr; 2022 Mar; 41(3):620-629. PubMed ID: 35124469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lab data and performance comparison by validating survival prediction models for patients with spinal metastases after radiotherapy.
    Yen HK; Hu MH; Zijlstra H; Groot OQ; Hsieh HC; Yang JJ; Karhade AV; Chen PC; Chen YH; Huang PH; Chen YH; Xiao FR; Verlaan JJ; Schwab JH; Yang RS; Yang SH; Lin WH; Hsu FM
    Radiother Oncol; 2022 Oct; 175():159-166. PubMed ID: 36067909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.